LONDON – The British government said on Friday it has asked its independent medicines regulator to assess AstraZeneca’s coronavirus vaccine as part of the formal approval process for the drug to be rolled out by the end of the year.
More than 1.4 million people have died since the novel coronavirus emerged in China late last year, and three drug developers — Pfizer/BioNTech, Moderna and AstraZeneca/Oxford University — are currently applying for approval for their vaccines to be used as early as December.
AstraZeneca has completed Phase III clinical trials of its vaccine, the last stage before regulatory approval.
But under British rules, the governmen…
Keep on reading: UK asks regulator to study AstraZeneca vaccine